Tudor Investment Corp
CBPO

Tudor Investment Corp’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Tudor Investment Corp’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,938
Closed -$222K – 2085
2016
Q1 		$222K Buy
1,938
+70
+4% +$8.21K 0.01% 1455
2015
Q4 		$266K Buy
+1,868
New +$216K 0.01% 1285

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tudor Investment Corp's CBPO Position: Q2 2016 in Review

Tudor Investment Corp sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2016, closing a stake of 1,938 shares — an estimated $222K sold.

Tudor Investment Corp first reported a position in CBPO in Q4 2015 and held it in 2 quarters. The position peaked at $266K in Q4 2015. 138 funds tracked by Wall St. Rank hold CBPO as of Q2 2016.

  • Tudor Investment Corp reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 1,938 China Biologic Products Holdings, Inc. shares in Q2 2016, an estimated $222K.
  • Tudor Investment Corp first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 2 quarters.
  • Tudor Investment Corp's China Biologic Products Holdings, Inc. position peaked at $266K in Q4 2015.
  • 138 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2016.

Based on Tudor Investment Corp's 13F filing for Q2 2016, filed 15 Aug 2016.